Ftse Mib
34.400,99
0,00%
DAX
20.242,57
-0,05%
S&P 500
5.872,16
-2,95%
NASDAQ
19.392,69
-3,56%
Bitcoin
101.241,14
1,18%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Mesoblast Limited (MESO) Mesoblast Limited (MESO) Notizie

Mesoblast Limited

MESO
17,20
4,69 (37,49%)
19 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
19/12/202401:08GLOBEMesoblast’s RYONCIL® is the First U.S. FDA-Approved..
18/12/202413:30GLOBEMesoblast to be Added to Nasdaq Biotechnology Index
13/12/202422:04EDGAR2Form F-3 - Registration statement by foreign private issuers
09/12/202422:21EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/12/202400:32GLOBEFDA Grants Revascor® (Rexlemestrocel-L) Regenerative..
03/12/202400:20GLOBERevascor Improves Survival and Reduces Major Morbidity in..
18/11/202412:47EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/10/202400:11GLOBEAppendix 4C Quarterly Activity Report for Quarter Ended..
09/10/202421:42EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
30/9/202402:55GLOBEMesoblast Option to Issue Up to US$50 Million Convertible..
29/8/202413:14EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/8/202401:27GLOBEMesoblast Reports Financial Results and Operational Update..
28/8/202401:25GLOBEMesoblast Financial Results and Corporate Update Webcast
31/7/202403:13GLOBEAppendix 4C Quarterly Activity Report for Quarter Ended June..
23/7/202413:53GLOBEFDA Accepts Mesoblast’s Biologics License Application (BLA)..
22/7/202402:45GLOBEPatient Enrollment Commenced in Pivotal Phase 3 Trial of..
09/7/202402:37GLOBEMesoblast Resubmits Biologics License Application (BLA) with..
01/7/202407:55GLOBEMesoblast to File Biologics License Application for Ryoncil®..
03/6/202402:23GLOBEMesoblast Corporate Presentation at Investor Conference
30/4/202403:05GLOBEAppendix 4c Quarterly Activity Report for Quarter Ended..
26/3/202414:25APSFDA Commentary Sends Biotech Soaring During Premarket Hours
26/3/202403:34GLOBEUnited States Food & Drug Administration (FDA) Notifies..
14/3/202400:30GLOBEMesoblast Successfully Completes Placement and Accelerated..
11/3/202400:54GLOBEUnited States Food & Drug Administration (FDA) Supports..
28/2/202423:57GLOBEMesoblast Reports Financial Results and Operational Update..
26/2/202413:00GLOBEMesoblast Financial Results and Corporate Update Webcast
15/2/202401:46GLOBEUnited States Food & Drug Administration (FDA) Grants..
01/2/202403:34EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/1/202403:13GLOBEAppendix 4C Quarterly Activity Report for Quarter Ended..
19/1/202401:28DJNMesoblast Gets FDA's Special Pediatric Designation for..
19/1/202400:36GLOBEUnited States Food & Drug Administration (FDA) Grants..
16/1/202412:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/1/202403:57EDGAR2Form F-6 POS - Post-effective amendments for immediately..
22/12/202323:13EDGAR2Form F-6 POS - Post-effective amendments for immediately..
Apertura: 13,10 Min: 12,20 Max: 13,7368
Chiusura: 12,51

La tua Cronologia

NASDAQ
MESO
Mesoblast
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network